Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients-authors' reply. - Sorbonne Université Access content directly
Journal Articles Alimentary Pharmacology & Therapeutics (Suppl) Year : 2021

Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients-authors' reply.

Fichier principal
Vignette du fichier
10.1111_apt.16340.pdf (69 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03777108 , version 1 (14-09-2022)

Identifiers

Cite

Stanislas Pol, Clovis Lusivika Nzinga, Fabrice Carrat. Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients-authors' reply.. Alimentary Pharmacology & Therapeutics (Suppl), 2021, 53 (9), pp.1050. ⟨10.1111/apt.16340⟩. ⟨hal-03777108⟩
99 View
16 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More